RxDoctor Payments Data

David Kusin, MD

Orthopaedic Surgery · Temple Terrace, FLNPI 1821448325

Payments from drug & device makers

$10,226in general payments, 2019–2025

Across 99 payments — averaging $103.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Encore Medical, LP$4K
  • Stryker$2K
  • MVP Orthopedics Inc$2K
  • Johnson & Johnson$242
  • Exactech, Inc.$149
  • Medical Device Business Services, Inc.$125
  • plus $397 from 6 others

What the payments were for

  • Speaking & faculty fees$1,50015%
  • Travel & lodging$2,03220%
  • Food & beverage$4,16941%
  • Education$2,52525%

General payments by program year

20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Encore Medical, LP52$4,398
Stryker30$2,469
MVP Orthopedics Inc4$2,446
Johnson & Johnson4$242
Exactech, Inc.1$149
Medical Device Business Services, Inc.1$125
Zimmer Biomet1$100
Exsomed Corporation1$97
Mission Medical Distribution, LLC1$86
Orthofix Medical, Inc.2$47
Surgical Specialties Corporation (US), Inc. (dba Corza Medical)1$47
Smith+Nephew1$20

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$10,226 in reported general payments places this provider in the 60th percentile of 1,263 orthopaedic surgery providers in Florida.

See all orthopaedic surgery providers in Florida

Medicare billing

Part B allowed, 2024
$11,642
Medicare patients
32
Services billed
161

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Meloxicam22$40

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Temple Terrace

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →